In this discussion, Professor Henning Bliddal, a renowned researcher in osteoarthritis treatment from Denmark, shares groundbreaking insights on Semaglutide. Originally aimed at weight loss, this drug has shown remarkable ability to alleviate knee pain for osteoarthritis sufferers. Henning reveals how weight loss reduces joint pressure, leading to improved mobility. He discusses the impressive results from clinical trials, practical tips for staying active, and ongoing research needed to ensure long-term benefits for patients.